Components of IGF-axis in growth disorders: a systematic review and patent landscape report

doi:10.1007/s12020-022-03063-2

. 2022 Jun;76(3):509-525.

doi: 10.1007/s12020-022-03063-2. Epub 2022 May 6.

Components of IGF-axis in growth disorders: a systematic review and patent landscape report

Amit Singh¹, Ketan Pajni², Inusha Panigrahi³, Navdeep Dhoat⁴, Sabyasachi Senapati², Preeti Khetarpal⁵

Affiliations

¹ Laboratory for Reproductive and Developmental Disorders, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, 151401, India.
² Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, 151401, India.
³ Department of Paediatric Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
⁴ Department of Paediatric Surgery, All India Institute of Medical Sciences, Bathinda, 151001, India.
⁵ Laboratory for Reproductive and Developmental Disorders, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, 151401, India. preetikhetarpal@cup.edu.in.

PMID: 35523998
DOI: 10.1007/s12020-022-03063-2

Components of IGF-axis in growth disorders: a systematic review and patent landscape report

Amit Singh et al. Endocrine. 2022 Jun.

. 2022 Jun;76(3):509-525.

doi: 10.1007/s12020-022-03063-2. Epub 2022 May 6.

Authors

Amit Singh¹, Ketan Pajni², Inusha Panigrahi³, Navdeep Dhoat⁴, Sabyasachi Senapati², Preeti Khetarpal⁵

Affiliations

¹ Laboratory for Reproductive and Developmental Disorders, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, 151401, India.
² Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, 151401, India.
³ Department of Paediatric Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
⁴ Department of Paediatric Surgery, All India Institute of Medical Sciences, Bathinda, 151001, India.
⁵ Laboratory for Reproductive and Developmental Disorders, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, 151401, India. preetikhetarpal@cup.edu.in.

PMID: 35523998
DOI: 10.1007/s12020-022-03063-2

Abstract

Purpose: In this review, epi/genetic mutations of IGF-axis components associated with growth disorders have been summarized alongwith assessment of relevant diagnostic and therapeutic technology through patent literature.

Methodology: PROSPERO protocol registration CRD42021279468. For scientific literature search Literature databases (PubMed, EMBASE, ScienceDirect, and Google Scholar) were queried using the appropriate syntax. Various filters were applied based on inclusion and exclusion criteria. Search results were further refined by two authors for finalizing studies to be included in this synthesis. For patent documents search Patent databases (Patentscope and Espacenet) were queried using keywords: IGF or IGFBP. Filters were applied according to International Patent Classification (IPC) and Cooperative Patent Classification (CPC). Search results were reviewed by two authors for inclusion in the patent landscape report.

Results: For scientific literature analysis, out of 545 search results, 196 were selected for review based on the inclusion criteria. For Patent literature search, out of 485 results, 37 were selected for this synthesis.

Conclusion: Dysregulation of IGF-axis components leads to various abnormalities and their key role in growth and development suggests epi/mutations or structural defects among IGF-axis genes can be associated with growth disorders and may explain some of the idiopathic short stature cases. Trend of patent filings indicate advent of recombinant technology for therapeutics.

Keywords: Diagnosis; Growth disorders; Insulin-like growth factors; Patent; Therapeutics.

PubMed Disclaimer

Cited by

From New Endocrine Entities Requiring New Approaches to New Approaches Leading to New Endocrine Entities.
Carsote M, Nistor CE, Ionovici N. Carsote M, et al. Diagnostics (Basel). 2023 Jan 31;13(3):518. doi: 10.3390/diagnostics13030518. Diagnostics (Basel). 2023. PMID: 36766623 Free PMC article.
[Discussion on the genetic mechanisms and efficacy of growth hormone therapy in children with idiopathic short stature].
Mamat M. Mamat M. Zhongguo Dang Dai Er Ke Za Zhi. 2024 Dec 15;26(12):1255-1260. doi: 10.7499/j.issn.1008-8830.2408040. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 39725386 Free PMC article. Review. Chinese.

References

1. B. Ergun-Longmire, M.P. Wajnrajch: Growth and Growth Disorders. In: K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, W.W. de Herder, K. Dhatariya, K. Dungan, J.M. Hershman, J. Hofland, S. Kalra, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, C.S. Kovacs, W. Kuohung, B. Laferrère, M. Levy, EA. McGee, R. McLachlan, J.E. Morley, M. New, J. Purnell, R. Sahay, F. Singer, M.A. Sperling, C.A. Stratakis, D.L. Trence, and D.P. Wilson, (eds.) Endotext. MDText.com, Inc., South Dartmouth (MA) (2000).
1. K. Forbes, M. Westwood, The IGF axis and placental function. Horm. Res. Paediatr. 69, 129–137 (2008). https://doi.org/10.1159/000112585 - DOI
1. R. Peoples, A. Milatovich, U. Francke, Hemizygosity at the insulin-like growth factor I receptor (IGF1R) locus and growth failure in the ring chromosome 15 syndrome. Cytogenet. Cell Genet. 70, 228–234 (1995). https://doi.org/10.1159/000134040 - DOI - PubMed
1. P. Prontera, L. Micale, A. Verrotti, V. Napolioni, G. Stangoni, G. Merla, A new homozygous IGF1R variant defines a clinically recognizable incomplete dominant form of SHORT syndrome. Hum. Mutat. 36, 1043–1047 (2015). https://doi.org/10.1002/humu.22853 - DOI - PubMed
1. I. Castilla-Cortazar, J.R. de Ita, G.A. Aguirre, F. Castorena-Torres, J. Ortiz-Urbina, M. García-Magariño, R.G. de la Garza, C. Diaz Olachea, M.I. Elizondo Leal, Fanconi anemia and laron syndrome. Am. J. Med. Sci. 353, 425–432 (2017). https://doi.org/10.1016/j.amjms.2017.02.001 - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information

[1] B. Ergun-Longmire, M.P. Wajnrajch: Growth and Growth Disorders. In: K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, W.W. de Herder, K. Dhatariya, K. Dungan, J.M. Hershman, J. Hofland, S. Kalra, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, C.S. Kovacs, W. Kuohung, B. Laferrère, M. Levy, EA. McGee, R. McLachlan, J.E. Morley, M. New, J. Purnell, R. Sahay, F. Singer, M.A. Sperling, C.A. Stratakis, D.L. Trence, and D.P. Wilson, (eds.) Endotext. MDText.com, Inc., South Dartmouth (MA) (2000).

[2] B. Ergun-Longmire, M.P. Wajnrajch: Growth and Growth Disorders. In: K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, W.W. de Herder, K. Dhatariya, K. Dungan, J.M. Hershman, J. Hofland, S. Kalra, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, C.S. Kovacs, W. Kuohung, B. Laferrère, M. Levy, EA. McGee, R. McLachlan, J.E. Morley, M. New, J. Purnell, R. Sahay, F. Singer, M.A. Sperling, C.A. Stratakis, D.L. Trence, and D.P. Wilson, (eds.) Endotext. MDText.com, Inc., South Dartmouth (MA) (2000).

[3] K. Forbes, M. Westwood, The IGF axis and placental function. Horm. Res. Paediatr. 69, 129–137 (2008). https://doi.org/10.1159/000112585 - DOI

[4] K. Forbes, M. Westwood, The IGF axis and placental function. Horm. Res. Paediatr. 69, 129–137 (2008). https://doi.org/10.1159/000112585 - DOI

[5] R. Peoples, A. Milatovich, U. Francke, Hemizygosity at the insulin-like growth factor I receptor (IGF1R) locus and growth failure in the ring chromosome 15 syndrome. Cytogenet. Cell Genet. 70, 228–234 (1995). https://doi.org/10.1159/000134040 - DOI - PubMed

[6] R. Peoples, A. Milatovich, U. Francke, Hemizygosity at the insulin-like growth factor I receptor (IGF1R) locus and growth failure in the ring chromosome 15 syndrome. Cytogenet. Cell Genet. 70, 228–234 (1995). https://doi.org/10.1159/000134040 - DOI - PubMed

[7] P. Prontera, L. Micale, A. Verrotti, V. Napolioni, G. Stangoni, G. Merla, A new homozygous IGF1R variant defines a clinically recognizable incomplete dominant form of SHORT syndrome. Hum. Mutat. 36, 1043–1047 (2015). https://doi.org/10.1002/humu.22853 - DOI - PubMed

[8] P. Prontera, L. Micale, A. Verrotti, V. Napolioni, G. Stangoni, G. Merla, A new homozygous IGF1R variant defines a clinically recognizable incomplete dominant form of SHORT syndrome. Hum. Mutat. 36, 1043–1047 (2015). https://doi.org/10.1002/humu.22853 - DOI - PubMed

[9] I. Castilla-Cortazar, J.R. de Ita, G.A. Aguirre, F. Castorena-Torres, J. Ortiz-Urbina, M. García-Magariño, R.G. de la Garza, C. Diaz Olachea, M.I. Elizondo Leal, Fanconi anemia and laron syndrome. Am. J. Med. Sci. 353, 425–432 (2017). https://doi.org/10.1016/j.amjms.2017.02.001 - DOI - PubMed

[10] I. Castilla-Cortazar, J.R. de Ita, G.A. Aguirre, F. Castorena-Torres, J. Ortiz-Urbina, M. García-Magariño, R.G. de la Garza, C. Diaz Olachea, M.I. Elizondo Leal, Fanconi anemia and laron syndrome. Am. J. Med. Sci. 353, 425–432 (2017). https://doi.org/10.1016/j.amjms.2017.02.001 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Components of IGF-axis in growth disorders: a systematic review and patent landscape report

Affiliations

Components of IGF-axis in growth disorders: a systematic review and patent landscape report

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical